CLAREMON, DAVID A.,DONG, CHENGGUO,FAN, YI,LEFTHERIS, KATERINA,LOTESTA, STEPHEN D.,SINGH, SURESH B.,TICE, COLIN M.,ZHAO, WEI,ZHENG, YAJUN,ZHUANG, LINGHANG
申请号：
CA2956360
公开号：
CA2956360A1
申请日:
2015.08.04
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver X receptor modulators, and which are useful in the treatment of diseases and disorders associated with the liver X receptor. Also provided are the compounds of Formula (I) and pharmaceutical compositions thereof for treating atherosclerosis, cardiovascular disease, Alzheimer's disease, dermatitis, dyslipidemia, cancer and other diseases or disorders.
